Severe and post-COVID-19 are associated with high expression of vimentin and reduced expression of N-cadherin

Abstract SARS-CoV-2 penetrates human cells via its spike protein, which mainly interacts with ACE2 receptors, triggering viral replication and an exacerbated immune response characterized by a cytokine storm. Vimentin III, an intermediate filament protein predominantly found in mesenchymal cells, ha...

Full description

Saved in:
Bibliographic Details
Main Authors: Esra Yilmaz, Dilek Yilmaz, Ercan Cacan
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-72192-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846147868256108544
author Esra Yilmaz
Dilek Yilmaz
Ercan Cacan
author_facet Esra Yilmaz
Dilek Yilmaz
Ercan Cacan
author_sort Esra Yilmaz
collection DOAJ
description Abstract SARS-CoV-2 penetrates human cells via its spike protein, which mainly interacts with ACE2 receptors, triggering viral replication and an exacerbated immune response characterized by a cytokine storm. Vimentin III, an intermediate filament protein predominantly found in mesenchymal cells, has garnered considerable attention in recent research due to its multifaceted biological roles and significance in the endothelial-mesenchymal transition (EndMT) during various fibrotic processes. However, the pathophysiological mechanisms linking vimentin to SARS-CoV-2 remain incompletely elucidated. In this study, we determined the expression profiles of vimentin in three cohorts: patients admitted to the intensive care unit with SARS-CoV-2 infection, individuals in the 6–12 month convalescent phase post-infection and COVID-19 negative controls. Our objective was to assess the association between peripheral blood biomarkers implicated in endothelial dysfunction and genes related to fibrosis. Serum levels of vimentin and N-cadherin were determined by ELISA, while vimentin gene expression was determined by qRT-PCR. In addition, we examined the correlation between clinical parameters and serum levels of vimentin and N-cadherin in severe COVID-19 patients and healthy counterparts. Our findings revealed elevated serum vimentin levels and increased gene expression in severe COVID-19 patients compared to healthy controls. Conversely, serum N-cadherin levels were diminished in both acute and convalescent stages of severe COVID-19 relative to healthy individuals. Notably, associations were observed between C-reactive protein, lactate dehydrogenase, lymphocyte count and vimentin levels in severe COVID-19 patients, indicative of endothelial dysfunction. Furthermore, our study identified vimentin and N-cadherin as potential diagnostic markers via ROC analysis. Overall, delineating the dysregulation of vimentin and N-cadherin due to SARS-CoV-2 infection in disease pathogenesis and tissue homeostasis offers novel insights for clinical management and targeted therapeutic interventions.
format Article
id doaj-art-24183d48f3e74a06bcddffc4a3c139c8
institution Kabale University
issn 2045-2322
language English
publishDate 2024-11-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-24183d48f3e74a06bcddffc4a3c139c82024-12-01T12:20:29ZengNature PortfolioScientific Reports2045-23222024-11-011411810.1038/s41598-024-72192-7Severe and post-COVID-19 are associated with high expression of vimentin and reduced expression of N-cadherinEsra Yilmaz0Dilek Yilmaz1Ercan Cacan2Department of Molecular Biology and Genetics, Faculty of Arts and Sciences, Tokat Gaziosmanpasa UniversityDepartment of Infectious Diseases and Clinical Microbiology, Yozgat City HospitalDepartment of Molecular Biology and Genetics, Faculty of Arts and Sciences, Tokat Gaziosmanpasa UniversityAbstract SARS-CoV-2 penetrates human cells via its spike protein, which mainly interacts with ACE2 receptors, triggering viral replication and an exacerbated immune response characterized by a cytokine storm. Vimentin III, an intermediate filament protein predominantly found in mesenchymal cells, has garnered considerable attention in recent research due to its multifaceted biological roles and significance in the endothelial-mesenchymal transition (EndMT) during various fibrotic processes. However, the pathophysiological mechanisms linking vimentin to SARS-CoV-2 remain incompletely elucidated. In this study, we determined the expression profiles of vimentin in three cohorts: patients admitted to the intensive care unit with SARS-CoV-2 infection, individuals in the 6–12 month convalescent phase post-infection and COVID-19 negative controls. Our objective was to assess the association between peripheral blood biomarkers implicated in endothelial dysfunction and genes related to fibrosis. Serum levels of vimentin and N-cadherin were determined by ELISA, while vimentin gene expression was determined by qRT-PCR. In addition, we examined the correlation between clinical parameters and serum levels of vimentin and N-cadherin in severe COVID-19 patients and healthy counterparts. Our findings revealed elevated serum vimentin levels and increased gene expression in severe COVID-19 patients compared to healthy controls. Conversely, serum N-cadherin levels were diminished in both acute and convalescent stages of severe COVID-19 relative to healthy individuals. Notably, associations were observed between C-reactive protein, lactate dehydrogenase, lymphocyte count and vimentin levels in severe COVID-19 patients, indicative of endothelial dysfunction. Furthermore, our study identified vimentin and N-cadherin as potential diagnostic markers via ROC analysis. Overall, delineating the dysregulation of vimentin and N-cadherin due to SARS-CoV-2 infection in disease pathogenesis and tissue homeostasis offers novel insights for clinical management and targeted therapeutic interventions.https://doi.org/10.1038/s41598-024-72192-7COVID-19VimentinN-cadherinEndMTEndothelial dysfunction
spellingShingle Esra Yilmaz
Dilek Yilmaz
Ercan Cacan
Severe and post-COVID-19 are associated with high expression of vimentin and reduced expression of N-cadherin
Scientific Reports
COVID-19
Vimentin
N-cadherin
EndMT
Endothelial dysfunction
title Severe and post-COVID-19 are associated with high expression of vimentin and reduced expression of N-cadherin
title_full Severe and post-COVID-19 are associated with high expression of vimentin and reduced expression of N-cadherin
title_fullStr Severe and post-COVID-19 are associated with high expression of vimentin and reduced expression of N-cadherin
title_full_unstemmed Severe and post-COVID-19 are associated with high expression of vimentin and reduced expression of N-cadherin
title_short Severe and post-COVID-19 are associated with high expression of vimentin and reduced expression of N-cadherin
title_sort severe and post covid 19 are associated with high expression of vimentin and reduced expression of n cadherin
topic COVID-19
Vimentin
N-cadherin
EndMT
Endothelial dysfunction
url https://doi.org/10.1038/s41598-024-72192-7
work_keys_str_mv AT esrayilmaz severeandpostcovid19areassociatedwithhighexpressionofvimentinandreducedexpressionofncadherin
AT dilekyilmaz severeandpostcovid19areassociatedwithhighexpressionofvimentinandreducedexpressionofncadherin
AT ercancacan severeandpostcovid19areassociatedwithhighexpressionofvimentinandreducedexpressionofncadherin